Pasireotide for the Treatment of Gastrointestinal Angiodysplasia in Endoscopic Treatment Failure

NCT02622906 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Angiodysplasia

Interventions

DRUG: Pasireotide
DRUG: Placebo

Sponsor

Robert Benamouzig